Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Journal of Radiation Research|May 28, 2014
High-dose concurrent chemo-proton therapy for Stage III NSCLC: preliminary results of a Phase II studyYoshiko Oshiro, Toshiyuki Okumura, Koichi Kurishima, et al.
Internal Medicine (Tokyo, Japan)|December 18, 2024
Concomitant Interstitial Pneumonia and Disseminated BCG Infection after Intravesical BCG Therapy: A Case ReportFumi Mochizuki, Midori Hanazawa, Manabu Komine, et al.
Cancer Treatment and Research Communications|May 19, 2026
Intracranial efficacy of combined immune checkpoint inhibitors and platinum plus etoposide therapy in patients with extensive-disease small-cell lung cancer and brain metastasesKenta Nakamura, Toshihiro Shiozawa, Hiroaki Tachi, et al.
Current Oncology (Toronto, Ont.)|November 26, 2024
Prognostic Factors for Patients with Small-Cell Lung Cancer Treated with Chemoimmunotherapy: A Retrospective Multicenter StudyTakashi Hatori, Takeshi Numata, Toshihiro Shiozawa, et al.
Clinical Lung Cancer|December 25, 2013
Outcomes and prognostic factors for recurrence after high-dose proton beam therapy for centrally and peripherally located stage I non--small-cell lung cancerAyae Kanemoto, Toshiyuki Okumura, Hitoshi Ishikawa, et al.
Cancer Diagnosis & Prognosis|January 6, 2025
Outcomes of Combined Atezolizumab Plus Chemotherapy in Non-small Cell Lung Cancer Patients in Clinical PracticeTakeshi Numata, Ryota Nakamura, Toshihiro Shiozawa, et al.
Anticancer Research|September 9, 2018
Real Clinical Practice of Using Afatinib Therapy in NSCLC Patients with an Acquired EGFR T790M MutationKunihiko Miyazaki, Tomohiro Tamura, Takayuki Kaburagi, et al.
Anticancer Research|May 31, 2024
Real Clinical Practice of Combined Atezolizumab Plus Chemotherapy in Patients With Small Cell Lung CancerSatoshi Ano, Norihiro Kikuchi, Shinichiro Okauchi, et al.
Medical Oncology (Northwood, London, England)|November 1, 2008
A population-based study of gefitinib in patients with non-small cell lung cancerKenji Hayashibara, Hiroaki Satoh, Yoko Shinohara, et al.
Molecular and Clinical Oncology|June 11, 2016
S-1-containing chemotherapy for patients with non-small-cell lung cancer: A population-based observational study by the Ibaraki thoracic integrative (POSITIVE) research groupMasaharu Inagaki, Yoko Shinohara, Takayuki Kaburagi, et al.
Pageof 9